Oppenheimer & CO Inc Schrodinger, Inc. Transaction History

Oppenheimer & CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$26.1 - $49.92 $114,448 - $218,899	4,385 New	4,385 $218,000
Q3 2022 Nov 14, 2022	SELL	$23.95 - $34.71 $16,884 - $24,470	-705 Reduced 7.35%	8,893 $222,000
Q2 2022 Aug 08, 2022	SELL	$21.39 - $35.9 $6,716 - $11,272	-314 Reduced 3.17%	9,598 $253,000
Q1 2022 May 12, 2022	BUY	$24.84 - $36.12 $10,457 - $15,206	421 Added 4.44%	9,912 $338,000
Q4 2021 Feb 02, 2022	SELL	$33.38 - $59.25 $60,618 - $107,598	-1,816 Reduced 16.06%	9,491 $331,000
Q3 2021 Nov 12, 2021	SELL	$53.75 - $76.55 $9,298 - $13,243	-173 Reduced 1.51%	11,307 $619,000
Q2 2021 Aug 03, 2021	BUY	$59.02 - $78.8 $52,645 - $70,289	892 Added 8.42%	11,480 $868,000
Q1 2021 May 10, 2021	BUY	$64.61 - $113.09 $157,777 - $276,165	2,442 Added 29.98%	10,588 $808,000
Q4 2020 Feb 11, 2021	BUY	$48.06 - $84.4 $391,496 - $687,522	8,146 New	8,146 $645,000

233

60.7M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.2B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.